Simon F Lacey

age ~61

from Media, PA

Get Report

Also known as:

Simon Lorelei Lacey
Francis Lacey Simon
Francie Lacey Simon
Franie Lacey Simon
Lacey Simon
Amy Roling
Amy Short

Phone and address:: 15 Brandywine Dr, Media, PA 19063
(610)8531618

Connected to:

Simon Lacey Phones & Addresses

15 Brandywine Dr, Media, PA 19063 • (610)8531618
Havertown, PA
942 E Meda Ave, Glendora, CA 91741 • (626)3358589
San Bernardino, CA
3041 Cedar Ave, Rialto, CA 92377 • (909)8741951
Azusa, CA
Durham, NC
Havertown, PA
Azusa, CA
Los Angeles, CA

Work

Company:

Asian development bank
Jul 2012 to Apr 2013
Address:

Manila
Position:

Team leader

Education

Degree:

LL.M.
School / High School:

Georgetown University Law Center
2011 to 2012
Specialities:

International Economic Law

Skills

Central Asia • Former Soviet Union • Sub-Saharan Africa • Eastern Europe • Africa • Government • Research • Technical Assistance • International Law • Intellectual Property • Policy • Capacity Building • International Trade • International Trade Law • Public International Law • International Relations • International Development • English • Policy Analysis • Government Relations • Public Policy • Program Management • French • Teaching • Writing • Governance • EU • Translation • Proposal Writing • Microsoft Office • Diplomacy • Foreign Investment • German • International Business • Change Management • Dispute Resolution • Report Writing • Corporate Law • Organizational Development • Qualitative Research • WTO • NAFTA • Free Trade Agreements • Regulatory Research • ASEAN • Trade Negotiations

Languages

English • German • French • Swiss German • Indonesian • Chinese • Russian • Korean

Industries

International Trade and Development

Resumes

International Trade Counsel | Market Access Advisor

view source

Location:

Greater Jakarta Area, Indonesia

Industry:

International Trade and Development

Work:

Asian Development Bank - Manila Jul 2012 - Apr 2013
Team Leader
Institute of International Economic Law - Washington D.C. Metro Area Aug 2011 - May 2012
Fellow
The ASEAN Secretariat - Jakarta Indonesia Jun 2011 - Aug 2011
Senior Trade Advisor
University of Stellenbosch - Stellenbosch, South Africa Jul 2009 - Nov 2009
Visiting Lecturer
Trade Law Chambers - Cape Town Area, South Africa Jan 2008 - May 2009
Senior Trade Advisor - Legal

Education:

Georgetown University Law Center 2011 - 2012
LL.M., International Economic Law Universiteit Leiden 2008 - 2012
PhD, International Economic Law National University of Singapore 2006 - 2007
Université de Fribourg/Universität Freiburg 1992 - 1998
Lic Iur, Law and European Law University of Berne

Skills:

Central Asia
Former Soviet Union
Sub-Saharan Africa
Eastern Europe
Africa
Government
Research
Technical Assistance
International Law
Intellectual Property
Policy
Capacity Building
International Trade
International Trade Law
Public International Law
International Relations
International Development
English
Policy Analysis
Government Relations
Public Policy
Program Management
French
Teaching
Writing
Governance
EU
Translation
Proposal Writing
Microsoft Office
Diplomacy
Foreign Investment
German
International Business
Change Management
Dispute Resolution
Report Writing
Corporate Law
Organizational Development
Qualitative Research
WTO
NAFTA
Free Trade Agreements
Regulatory Research
ASEAN
Trade Negotiations

Languages:

English
German
French
Swiss German
Indonesian
Chinese
Russian
Korean

Us Patents

Polyomavirus Cellular Epitopes And Uses Therefor
view source
US Patent:

7468186, Dec 23, 2008
Filed:

Jul 24, 2006
Appl. No.:

11/491542
Inventors:

Simon F. Lacey - Glendora CA, US
Assignee:

City of Hope - Duarte CA
International Classification:

A61K 39/12
US Classification:

4242041, 530300
Abstract:

The present invention relates to HLA-A*02-restricted cellular epitopes within the VP1 polypeptide of a human polyomavirus, BK virus, which is associated with polyomavirus-associated nephropathy in kidney transplant patients. Preferred peptides correspond to amino acids residues 107-116, 108-116 and 44-52 of BKV VP1, and are processed in vivo in natural infection with BKV. Effector T cell populations stimulated by the peptides represent functional CTLs as assessed by cytotoxicity and cytokine production, and are reactive against cells presenting both the BKV peptides above and the JC virus homolog sequences.

Polyomavirus Diagnostic Reagents
view source
US Patent:

7662912, Feb 16, 2010
Filed:

Nov 19, 2008
Appl. No.:

12/273808
Inventors:

Simon F. Lacey - Glendora CA, US
Assignee:

City of Hope - Duarte CA
International Classification:

C08J 3/28
US Classification:

530300
Abstract:

The present invention relates to HLA-A*02-restricted cellular epitopes within the VP1 polypeptide of human polyomaviruses, which are useful as diagnostic reagents for virus infection. Preferred peptides correspond to amino acids residues 107-116, 108-116 and 44-52 of BKV VP1, and are processed in vivo in natural infection with BKV. Effector T cell populations stimulated by the peptides represent functional CTLs as assessed by cytotoxicity and cytokine production, and are reactive against cells presenting both the BKV peptides above and the JC virus homolog sequences.

Car T Cell Therapies With Enhanced Efficacy
view source
US Patent:

20210047405, Feb 18, 2021
Filed:

Apr 26, 2019
Appl. No.:

17/050805
Inventors:

- Basel, CH
- Philadelphia PA, US
Joseph A. Fraietta - Williamstown NJ, US
Simon Lacey - Media PA, US
Jan J. Melenhorst - Cherry Hill NJ, US
Carl H. June - Merion Station PA, US
International Classification:

C07K 16/28
A61K 35/17
C12N 15/86
C12N 5/0783
A61P 35/02
C07K 14/725
G01N 33/50
Abstract:

The invention provides methods for manufacturing optimized CAR T cell therapies and uses thereof. Specifically, the invention provides parameters that can be measured, e.g., evaluated, to manufacture CAR T cell therapies with optimized properties. The invention further provides methods of use in connection with said optimized CART cells.

Combination Therapies Of Chimeric Antigen Receptors And Pd-1 Inhibitors
view source
US Patent:

20190151365, May 23, 2019
Filed:

Jul 28, 2017
Appl. No.:

16/321322
Inventors:

- Basel, CH
- Philadelphia PA, US
Jennifer Brogdon - Sudbury MA, US
John Scott Cameron - Belmont MA, US
William Chou - Maplewood NJ, US
Stephan Grupp - Havertown PA, US
Randi Isaacs - Basking Ridge NJ, US
Carl H. June - Merion Station PA, US
Simon Lacey - Media PA, US
Shannon Maude - Conshohocken PA, US
Jan J. Melenhorst - Cherry Hill NJ, US
Stephen Shuster - Springfield PA, US
Assignee:

Novartis AG - Basel
The Trustees of the University of Pennsylvania - Philadelphia PA
International Classification:

A61K 35/17
C07K 14/725
C07K 16/28
A61P 35/00
G01N 33/574
Abstract:

Provided are compositions and methods for treating diseases, e.g., cancers, e.g., diseases associated with expression of an antigen, e.g., CD 19, comprising administering a cell that expresses a chimeric antigen receptor (CAR) specific to the antigen, e.g., CD19, in combination with a PD-1 inhibitor.

Biomarkers Predictive Of Cytokine Release Syndrome
view source
US Patent:

20180252727, Sep 6, 2018
Filed:

Sep 2, 2016
Appl. No.:

15/757123
Inventors:

Alfred Garfall - Wallingford PA, US
Alex Ganetsky - Philadelphia PA, US
Saar Gill - Philadelphia PA, US
Simon Lacey - Media PA, US
Jan J. Melenhorst - Cherry Hill NJ, US
David Teachey - Rutledge PA, US
- Philadelphia PA, US
Assignee:

Mayo Foundation for Medical Education and Research - Rochester MN
International Classification:

G01N 33/68
A61K 45/06
A61K 39/395
C07K 16/28
C07K 14/705
C07K 14/725
A61K 35/17
C12Q 1/6876
A61K 31/675
A61P 37/00
A61P 29/00
Abstract:

The present disclosure relates to the identification and use of biomarkers (e.g., analytes, analyte profiles, or markers (e.g., gene expression and/or protein expression profiles)) with clinical relevance to cytokine release syndrome (CRS).